SIStockInvestingSI.com

NYSE · BSX · Medical Devices

Boston Scientific (BSX) stock analysis

$44.51−2.35%Data as of Oct 21, 2026
  • BSX lost 0.9% over the past month versus 0.0% for the S&P 500, ranking 333rd of 497 S&P 500 stocks.
  • Over 12 months it returned −55.7%, 71.5 points behind the S&P 500, and trades 57.6% below its 52-week high.
  • In the last 30 days 0 analysts raised earnings estimates and 11 cut; forward EPS moved −1.5% (−8.9% over 90 days).
  • It sits in the Cardiovascular & structural heart segment of the Healthcare Value Chain, where the 1-month median return is −0.4%.
  • The daily chart reads Trend transition · Trend repair (since Oct 21, 2026).
Market cap$64.5B
12-month return−55.7%
Forward P/E13.0×
Mean target vs price+33.3%

One-year price with 50- and 200-day averages

Open in Hub
46.764.482.299.9JanAprJulOct
44.5150-day200-day

Performance vs the market

Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.

BSX−0.9%
Sector median−8.7%
S&P 5000.0%
BSX+2.1%
Sector median−5.4%
S&P 500+4.7%
BSX−31.4%
Sector median−1.5%
S&P 500+8.7%
BSX−55.7%
Sector median+1.7%
S&P 500+15.8%
1-month rank in the S&P 500333 / 497
3-month rank in its sector · Healthcare283 / 720

Chart structure

Read by our daily-bar structure engine from swing highs, swing lows and moving averages.

Trend transition · Trend repairAwaiting confirmation

Holding since Oct 21, 2026

  • Price and averages have mixed alignment
  • EMA50 fell over the last ten sessions
  • Confirmed swing highs and lows are rising
  • Intermediate and long-term directions differ
  • Neither a stable trend nor a range is confirmed
This pattern on this stock

54 occurrences in 10 years. The median move over the next 20 sessions was 0.0%, positive 50% of the time, against +1.2% for any day in the same period.

Reference zone, stop and targets for this structureSee the trade plan in Hub ↗

Analyst earnings revisions

Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.

Forward EPS$3.38
30-day change−1.5%
90-day change−8.9%
Mean target$59.34 +33.3%
Raised (30d) 0Cut (30d) 11

29 analysts cover the stock

Fundamental shape vs peers

Six dimensions on fixed scales. The filled shape is the company; the outline is the peer average.

Open the full Radar with every ratio
ValuationRevisionsMomentumGrowthCashProfit

Ahead of peersValuation

Behind peersMomentum, Revisions

PeersABT · MDT · SYK · EW

Where it sits in the supply chain

Healthcare Value Chain · Drugs & devices

Explore the full chain map in Hub
Its segment
Cardiovascular & structural heart−0.4%
BSX−0.9%1 monthMDT+3.3%1 monthEW−0.4%1 month

Electrophysiology, stents and heart valves, where new technologies shift share as they ramp.

Sells into
Hospitals & care delivery+8.4%
HCA+4.9%1 monthUNH+11.8%1 month

Also on: Medtech, Diagnostics & Care

Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps

Risk profile

Max drawdown, 12M−60.4%
Volatility, 60D34.0%
From 52-week high−57.6%
From 52-week low+7.0%
Trailing P/E18.0×
Forward P/E13.0×

Themes

  • MedTech3M rank 44 / 90
MDTMedtronicEWEdwards Lifesciences CorporatioUNHUnitedHealth GroupABTAbbott LaboratoriesSYKStrykerDXCMDexCom, Inc.STESTERIS plc (Ireland)ZBHZimmer Biomet Holdings, Inc.

Track this stock every day

Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.

Open in Hub ↗